GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹40 Cr | ₹30 Cr | ₹24 Cr | ₹19 Cr | ₹21 Cr |
What is the latest Total Current Liabilities ratio of GENNEX LABORATORIES ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹40 Cr |
Mar2023 | ₹30 Cr |
Mar2022 | ₹24 Cr |
Mar2021 | ₹19 Cr |
Mar2020 | ₹21 Cr |
How is Total Current Liabilities of GENNEX LABORATORIES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹40 Cr | 36.57 | |
Mar2023 | ₹30 Cr | 21.91 | |
Mar2022 | ₹24 Cr | 27.25 | |
Mar2021 | ₹19 Cr | -8.79 | |
Mar2020 | ₹21 Cr | - |
Compare Total Current Liabilities of peers of GENNEX LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GENNEX LABORATORIES | ₹317.0 Cr | 1.4% | -15.6% | -34.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,764.0 Cr | 0.6% | -2.1% | 16.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,010.0 Cr | 4.3% | 6.5% | 63.9% | Stock Analytics | |
CIPLA | ₹118,905.0 Cr | 3.6% | 0.2% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,523.0 Cr | 3% | -8.4% | 0% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,015.0 Cr | 3.2% | -1% | 27.4% | Stock Analytics |
GENNEX LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GENNEX LABORATORIES | 1.4% |
-15.6% |
-34.7% |
SENSEX | 0.5% |
0.3% |
7.9% |
You may also like the below Video Courses